CORONA Remedies Limited (CORONA.BO)
BSE · INR · Healthcare · Drug Manufacturers - General
₹2,150.85 (+5.44%) as of
Key statistics
- Market cap
- 131.55B
- P/E (TTM)
- 65.61
- Forward P/E
- 41.02
- EPS (TTM)
- 32.78
- Dividend yield
- 0.49%
- 52-week range
- 1,336.95 – 2,285.00
- Revenue (TTM)
- 14.79B
- Profit margin
- 13.46%
- Analyst target
- ₹2,304.67
- Volume
- 1.17k
About CORONA Remedies Limited
CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women's healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, nutraceuticals, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Ahmedabad, India
- Employees
- 5,153
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.